2/24
10:23 am
tvtx
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory [Yahoo! Finance]
2/24
07:42 am
tvtx
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms [Seeking Alpha]
Low
Report
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms [Seeking Alpha]
2/24
07:10 am
tvtx
Travere Therapeutics (TVTX) Reports 144% Annual Growth in Filspari Sales for 2025 [Yahoo! Finance]
Low
Report
Travere Therapeutics (TVTX) Reports 144% Annual Growth in Filspari Sales for 2025 [Yahoo! Finance]
2/23
12:32 pm
tvtx
A Look At Travere Therapeutics (TVTX) Valuation After Q4 Earnings Beat And FILSPARI Regulatory Progress [Yahoo! Finance]
Medium
Report
A Look At Travere Therapeutics (TVTX) Valuation After Q4 Earnings Beat And FILSPARI Regulatory Progress [Yahoo! Finance]
2/20
12:16 am
tvtx
Travere Therapeutics Inc (TVTX) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Travere Therapeutics Inc (TVTX) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
2/19
07:23 pm
tvtx
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates [Yahoo! Finance]
Medium
Report
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates [Yahoo! Finance]
2/19
05:06 pm
tvtx
Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss [Yahoo! Finance]
Medium
Report
Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss [Yahoo! Finance]
2/19
04:01 pm
tvtx
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2/18
01:24 am
tvtx
Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market [Yahoo! Finance]
Low
Report
Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market [Yahoo! Finance]
2/17
02:38 am
tvtx
How New Filspari Reviews And Price Targets Are Rewriting The Story For Travere Therapeutics (TVTX) [Yahoo! Finance]
Low
Report
How New Filspari Reviews And Price Targets Are Rewriting The Story For Travere Therapeutics (TVTX) [Yahoo! Finance]
2/12
04:59 pm
tvtx
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/12
04:30 pm
tvtx
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
2/11
05:00 pm
tvtx
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6
08:03 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Travere Therapeutics (NASDAQ:TVTX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
2/4
05:05 pm
tvtx
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit [Yahoo! Finance]
Medium
Report
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit [Yahoo! Finance]
2/4
04:30 pm
tvtx
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
Medium
Report
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
2/2
01:33 am
tvtx
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? [Yahoo! Finance]
Medium
Report
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? [Yahoo! Finance]
1/30
08:50 pm
tvtx
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
Medium
Report
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
1/29
12:01 pm
tvtx
Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think [Seeking Alpha]
Low
Report
Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think [Seeking Alpha]
1/28
07:10 am
tvtx
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
1/27
07:54 am
tvtx
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses
Low
Report
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses
1/24
04:36 pm
tvtx
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? [Yahoo! Finance]
Medium
Report
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? [Yahoo! Finance]
1/24
02:26 am
tvtx
BofA Remains Positive on Travere Despite FDA Decision Delay for Filspari [Yahoo! Finance]
Medium
Report
BofA Remains Positive on Travere Despite FDA Decision Delay for Filspari [Yahoo! Finance]
1/16
06:00 am
tvtx
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
1/15
08:14 am
tvtx
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]
Low
Report
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]